<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://mpkb.org/lib/exe/css.php?s=feed" type="text/css"?>
<rss version="2.0">
    <channel xmlns:g="http://base.google.com/ns/1.0">
        <title>Marshall Protocol Knowledge Base - home:othertreatments:antimetabolites</title>
        <description></description>
        <link>https://mpkb.org/</link>
        <lastBuildDate>Mon, 06 Apr 2026 16:13:55 +0000</lastBuildDate>
        <generator>FeedCreator 1.8</generator>
        <image>
            <url>https://mpkb.org/_media/wiki/dokuwiki.svg</url>
            <title>Marshall Protocol Knowledge Base</title>
            <link>https://mpkb.org/</link>
        </image>
        <item>
            <title>Methotrexate (MTX)</title>
            <link>https://mpkb.org/home/othertreatments/antimetabolites/methotrexate?rev=1663188833&amp;do=diff</link>
            <description>&lt;table&gt;&lt;tr&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;09.16.2017&lt;/th&gt;&lt;th colspan=&quot;2&quot; width=&quot;50%&quot;&gt;current&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 11:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 11:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;[{{ :home:othertreatments:antibacterials:ecoli-dhfr-mtx_small.jpeg|**Methotrexate complexed with E.coli DHFR**}}]&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;[{{ :home:othertreatments:antibacterials:ecoli-dhfr-mtx_small.jpeg|**Methotrexate complexed with E.coli DHFR**}}]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;Methotrexate and trimethoprim are very similar drugs. The both act on [[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://en.wikipedia.org/wiki/DHFR|Dihydrofolate Reductase (DHFR)]]. To the right is methotrexate complexed with //E. coli// DHFR.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;Methotrexate and trimethoprim are very similar drugs. The both act on [[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://en.wikipedia.org/wiki/DHFR|Dihydrofolate Reductase (DHFR)]]. To the right is methotrexate complexed with //E. coli// DHFR.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Both trimethoprim and MTX have a very high affinity for the Bacterial DHFR, while Trimethoprim has a lower affinity for human DHFR than MTX. You would need a very large dose of Trimethoprim in a human being to equal the DHFR effects of a typical rheumatologic MTX dosing regime.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;Both trimethoprim and MTX have a very high affinity for the Bacterial DHFR, while Trimethoprim has a lower affinity for human DHFR than MTX. You would need a very large dose of Trimethoprim in a human being to equal the DHFR effects of a typical rheumatologic MTX dosing regime.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;//Inter alia//, DHFR catalyzes THFR, an essential step in the production of [[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://en.wikipedia.org/wiki/Purine|purines]], [[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://en.wikipedia.org/wiki/Thymidine_monophosphate|thymidine monophosphate]], and some amino acids.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;//Inter alia//, DHFR catalyzes THFR, an essential step in the production of [[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://en.wikipedia.org/wiki/Purine|purines]], [[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://en.wikipedia.org/wiki/Thymidine_monophosphate|thymidine monophosphate]], and some amino acids.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;MTX therefore inhibits the synthesis of DNA and proteins, and this is the action typically attributed to it in a therapeutic environment. However, purines are very active compounds and form the basis of many human metabolites. I would note that a purine-like imidazole ring is part of the olmesartan molecule.&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;MTX therefore inhibits the synthesis of DNA and proteins, and this is the action typically attributed to it in a therapeutic environment. However, purines are very active compounds and form the basis of many human metabolites. I would note that a purine-like imidazole ring is part of the olmesartan molecule.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 37:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 37:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;It is not harmful to the body to discontinue MTX abruptly. This is in contrast to Prednisone, where abruptly stopping can cause a number of serious problems. Some doctors think there is a risk of rebound inflammation from stopping methotrexate abruptly. Taking a few weeks to wean from MTX, while probably not necessary, is the cautious approach to avoid the symptoms of rebound inflammation.&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;It is not harmful to the body to discontinue MTX abruptly. This is in contrast to Prednisone, where abruptly stopping can cause a number of serious problems. Some doctors think there is a risk of rebound inflammation from stopping methotrexate abruptly. Taking a few weeks to wean from MTX, while probably not necessary, is the cautious approach to avoid the symptoms of rebound inflammation.&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;However, for hepatitis patients currently using methotrexate, withdrawal may carry serious risks. Therefore [[&lt;strong class=&quot;diff-mark&quot;&gt;http&lt;/strong&gt;://www.hss.edu/professional-conditions_methotrexate-contraindicated-in-rheumatoid-arthritis-hepatitis-b-c.asp|methotrexate is now considered contraindicated for hepatitis patients]].&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;However, for hepatitis patients currently using methotrexate, withdrawal may carry serious risks. Therefore [[&lt;strong class=&quot;diff-mark&quot;&gt;https&lt;/strong&gt;://www.hss.edu/professional-conditions_methotrexate-contraindicated-in-rheumatoid-arthritis-hepatitis-b-c.asp|methotrexate is now considered contraindicated for hepatitis patients]].&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;{{tag&amp;gt;Other_medication}}&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 46:&lt;/td&gt;
&lt;td class=&quot;diff-blockheader&quot; colspan=&quot;2&quot;&gt;Line 47:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt; &lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;&amp;lt;nodisp&lt;/strong&gt;&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt;{{tag&lt;/strong&gt;&amp;gt;&lt;strong class=&quot;diff-mark&quot;&gt;antibiotics non-MP_therapies}} &lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt; &lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt; &lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;-&lt;/td&gt;&lt;td class=&quot;diff-deletedline&quot;&gt;&lt;strong class=&quot;diff-mark&quot;&gt; &lt;/strong&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;===== Notes and comments =====&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;+&lt;/td&gt;&lt;td class=&quot;diff-addedline&quot;&gt;&amp;lt;/nodisp&amp;gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-lineheader&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class=&quot;diff-context&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
            <author>anonymous@undisclosed.example.com (Anonymous)</author>
            <pubDate>Wed, 14 Sep 2022 20:53:53 +0000</pubDate>
        </item>
    </channel>
</rss>
